Several equities research analysts have recently issued reports on the stock. KeyCorp decreased their price target on shares of UnitedHealth Group from $400.00 to $350.00 and set an "overweight" rating for the company in a research note on Wednesday, July 30th. Royal Bank Of Canada decreased their price target on shares of UnitedHealth Group from $355.00 to $286.00 and set an "outperform" rating for the company in a research note on Wednesday, July 30th. Oppenheimer decreased their price target on shares of UnitedHealth Group from $400.00 to $325.00 and set an "outperform" rating for the company in a research note on Wednesday, July 30th. Wall Street Zen lowered shares of UnitedHealth Group from a "buy" rating to a "hold" rating in a research note on Saturday, May 24th.